Potential for replacing warfarin with a direct oral anticoagulant for endoscopic mucosal resection in the colorectum: A multicenter, open‐label, randomized controlled trial

DEN Open(2022)

引用 0|浏览4
暂无评分
摘要
AR for colorectal EMR may prove safe and has the potential to shorten hospital stay and reduce medical costs, though we were unable to evaluate the primary endpoint due to insufficient sample size.
更多
查看译文
关键词
direct oral anticoagulant,endoscopic mucosal resection,heparin bridging,randomized controlled trial,warfarin
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要